We develop technology that accelerates and de-risks pharmaceutical research and development
Our mission is to eliminate inaccuracy and waste when translating drug candidates to clinical trials using AI-driven, multi-disciplinary quantitative methods that predict patient outcomes.
What if?
Introducing a first-in-class decision engine that enables discovery and R&D de-risking, unlike anything you’ve worked with before.
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
BIOiSIM-accelerated assets in pipeline
Our service offerings deliver insights for pharmaceutical companies, biotechs, and academic & research institutions. We also partner in risk-sharing collaborations to develop promising drugs.
PulmoSIM Therapeutics, a wholly-owned subsidiary of VeriSIM Life, identifies licensable candidates for preclinical translation and out-licensing to commercialization partners.
.svg)
.png)
Making a difference
Addressing the unmet needs of patients everywhere is our passion. Are you motivated by ownership in your work and a mission to make a difference? Do you embrace diversity? Is continuous learning part of your DNA? This is what drives the team at VeriSIM Life every day. Learn more about our mission and make up.
News and events
.svg)
We care about your data, and we'd use cookies only to improve your experience. By using this website, you accept our cookie policy.
